US5016633A - Artificial retina device - Google Patents

Artificial retina device Download PDF

Info

Publication number
US5016633A
US5016633A US07/390,562 US39056289A US5016633A US 5016633 A US5016633 A US 5016633A US 39056289 A US39056289 A US 39056289A US 5016633 A US5016633 A US 5016633A
Authority
US
United States
Prior art keywords
layer
retinal
retina
cells
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/390,562
Inventor
Alan Y. Chow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMI Intelligent Medical Implants AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US07/390,562 priority Critical patent/US5016633A/en
Priority to US07/549,094 priority patent/US5024223A/en
Priority to CA002022544A priority patent/CA2022544C/en
Priority to EP90308575A priority patent/EP0460320B1/en
Priority to ES90308575T priority patent/ES2110410T3/en
Priority to DE69031908T priority patent/DE69031908T2/en
Application granted granted Critical
Publication of US5016633A publication Critical patent/US5016633A/en
Assigned to OPTOBIONICS CORPORATION reassignment OPTOBIONICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHOW, ALAN Y.
Assigned to ARCH VENTURE FUND V, L.P., ATV ENTREPRENEURS V, L.P., CHO, ALAN, MEDTRONIC INTERNATIONAL, LTD., ARCH V ENTREPRENEURS FUND, L.P., POLARIS VENTURE PARTNERS FOUNDERS' FUND, L.P., POLARIS VENTURE PARTNERS III, L.P., POLARIS VENTURE PARTNERS, L.P., POLARIS VENTURE PARTNERS FOUNDERS' FUND III, L.P., ARCH VENTURE FUND III, L.P., POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND III, L.P., ADVANCED TECHNOLOGY VENTURES V, L.P. reassignment ARCH VENTURE FUND V, L.P. SECURITY AGREEMENT Assignors: OPTOBIONICS CORPORATION
Assigned to IMI INTELLIGENT MEDICAL IMPLANTS AG reassignment IMI INTELLIGENT MEDICAL IMPLANTS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: OPTOBIONICS CORPORATION
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0543Retinal electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/08Devices or methods enabling eye-patients to replace direct visual perception by another kind of perception
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36046Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the eye

Definitions

  • the present invention is directed to a medical product and operation procedure which can be used to correct vision loss or even complete blindness caused by certain retinal diseases.
  • a variety of retinal diseases for example, cause vision loss or blindness by destruction of the choroid, choriocapillaris, and the outer retinal layers.
  • the outer layers include Bruch's membrane and retinal pigment epithelium, the loss of which results in degeneration of the inner retinal photoreceptor layer. These diseases, however, often spare much of the remaining inner retinal layers of the outer nuclear, outer plexiform, inner nuclear, inner plexiform, ganglion cell and nerve fiber layers.
  • the current invention involves the use of an electronic device, a photosensitive array, that is capable of mimicking the signals that would otherwise be produced by the damaged inner retinal photoreceptor layer.
  • an electronic device a photosensitive array
  • Another prior device involved a unit consisting of a supporting base onto which a photo-sensitive material such as selenium is coated. This device was to have been inserted through an external scleral incision made at the posterior pole resting between the sclera and choroid or between the choroid and retina. Light simulation would then cause a potential to develop on the photosensitive surface causing ions to be produced which would then theoretically migrate into the retina causing stimulation.
  • having no discrete surface structure to restrict the directional flow of charges, lateral migration and diffusion of charges would be allowed thereby preventing any resolution capability.
  • Placement of this device between the sclera and choroid would also virtually block the discrete migration of ions to the photoreceptor and inner retinal layers due to the presence of the choroid, choriocapillaris, Bruch's membrane and the retinal pigment epithelial layer. Placement of the device between the choroid and the retina would still interpose Bruch's membrane and the retinal pigment epithelial layer in the pathway of discrete ion migration. Also, as this device would have had to be inserted into or through the highly vascular choroid of the posterior pole, severe subchoroidal, intraretinal and or intraorbital hemorrhage would likely have resulted along with disruption of blood flow to the posterior pole. One such device was apparently constructed and implanted into a patient's eye resulting in reported light perception but no formed imagery.
  • the artificial retina device of this invention circumvents the limitations of previous devices. It is composed of a plurality of discrete photodiodes with their individual electrodes disposed on one surface of a substrate, the photodiodes each being connected to a common electrical ground on the other side of the substrate. Each photodiode includes an active electrode layer overlaying a photosensitive layer, and each is connected to an electrical ground.
  • the photodiodes have electrical outputs that correspond to the amplitude of the light incident on said device, whereby said device can be implanted in the eye intermediate the inner retinal layer and the retinal pigment epithelium of outer layer of the retina, so that each of said photodiodes will stimulate directly individual or small groups of cells in the inner retinal layer corresponding to the light incident on said device.
  • an amplitude-modulated electric potential, varying with illumination, produced by each photodiode will stimulate the overlying inner retinal layer consisting of photoreceptors, bipolar cells and horizontal cells. As these cells normally both receive and produce analog amplitude-modulated currents, the analog amplitude-modulated output of the device is well suited for stimulation of these cells.
  • the amplitude-modulated signals of the bipolar cells are then modified and converted by the amacrine and ganglion cells to a frequency-modulated signal as is the normal biological event in the innermost area of the inner retinal layer for distant transmission through the optic nerve to the lateral geniculate area of the brain. Because the complex conversion of the amplitude-modulated signal to the frequency-modulated signal is left to intrinsic retinal mechanisms, the formed vision produced is much enhanced compared to devices that attempt to stimulate the nerve fiber layer directly with electronic and amplifier reconstructed frequency-modulated signals.
  • FIG. 1A is a perspective view of an artificial retina device of the present invention
  • FIG. 1B is a perspective view of an alternative form of an artificial retina device of the present invention.
  • FIG. 1C (1)-(4) are perspective views of four alternative embodiments of the present invention.
  • FIG. 2A is a perspective, cross-sectional view of a first photodiode array for use in an artificial retina device of the present invention
  • FIG. 2B is a perspective, cross-sectional view of a second photodiode array for use in an artificial retina device of the present invention
  • FIG. 3A-3C illustrate steps in a surgical procedure for implanting an artificial retina device of the present invention.
  • FIG. 4 is an exploded, cross-sectional view of an artificial retinal device of the present invention as implanted in the eye.
  • an artificial retina device 10 is generally circular in shape with an integral grasping member (FIG. 1B) or a projecting grasping member (FIG. 1A) to grasp the device while it is being inserted.
  • the device ranges from 3 mm to 20 mm in diameter and from 0.005 mm to 2 mm in thickness.
  • the device 10 may be round (FIG. 1C (3)), oval (FIG. 1C (4)) elliptical (FIG. 1C (2)), or irregular (FIG. 1C (1)) in shape.
  • the surface contours may be flat or curved to match the curvature of the retina.
  • the edges or selected areas of the anterior 14 or posterior 16 (FIG. 2A) surfaces may be fashioned with ridges or other protrusions to improve stability within the retina and to improve biological acceptability.
  • the device may also have ledges, lips or loops to aid manipulation during implantation. In addition, it may also have openings (not shown) between the two surfaces to allow passage of intraretinal nourishment and tissue ingrowth to maintain the device securely in the retina.
  • the details of the photodiode construction of the artificial retina device of the present invention consist of multiple layers of both pure and doped silicon deposited and etched.
  • An insulated or noninsulated polysilicon active electrode structure 13a projects from the surface in one embodiment (FIG. 2A), or a flat polysilicon active electrode surface 13b is constructed in another alternative embodiment (FIG. 2B) to transfer a current from the photodiode to the overlying photoreceptor, bipolar and inner retinal cell layers as explained in detail below.
  • the polysilicon electrode structure 13a or 13b can be made by standard semiconductor plasma and/or wet etch techniques.
  • the artificial retina device of the present invention is, therefore, a large array of photovoltaic microphotodiodes of the PiN type.
  • Each microphotodiode consists of a shallow P-doped photoactive layer 18 overlaying an intrinsic layer 20 which in turn overlays a N-doped layer 6.
  • a conductive layer 22 of polysilicon that forms the common complimentary electrode or ground.
  • a common complimentary electrode is shown, but the device can be constructed with a discrete complimentary electrode for each microphotodiode.
  • a layer of silicon nitrate 24 covering the entire surface except for openings (or on the unmasked areas) 26 that establish electrode contact areas for the polysilicon active electrode 13a (or 13b).
  • the PiN layers may be reversed (NIP) or modified to facilitate reversal of the device polarity.
  • a plurality of nodes 28 are formed from a plurality of microphotodiodes described above.
  • the designed current output of each self-powered photodiode node is on the order of 50 nA when the device is exposed to average room lighting. However, the electrical current output may be designed to be greater or less than this value depending upon the stimulation requirement of the overlying cell layer.
  • a supplemental bias activation current may also be provided by an insulated wire or series of insulated wires leading from the device from the eye into an external or internally implanted battery unit.
  • the device 10 of this invention is inserted into the vitreous cavity of the eye 30 via a pars plana incision 32.
  • a horizontal incision 34 (FIG. 3B) is then made through the retina from the vitreous side in the temporal portion of the posterior pole into the potential space between the photoreceptor layer and the retinal pigment epithelium.
  • a horizontal incision 34 made at this location will avoid cutting inner retinal vasculature and will be parallel to coursing nerve fiber layers 36, therefore, also avoiding their injury.
  • Illumination for the surgical procedure is provided by a optical fiber light pipe 38.
  • the potential space is then be opened by canula irrigation of a balanced salt solution into the intraretinal space.
  • the device is then placed into the intraretinal cavity (FIG. 3C) at the posterior pole under the macula area. Specifically, the device is placed between the retinal pigment epithelium 58 (FIG. 4) and photoreceptor layer 54, or if photoreceptor layer 54 is atrophied or lost then between the retinal pigment epithelium 58 and the bipolar and horizontal cell layer 52. The device is positioned such that the electrical ground 22 is overlaying the retinal pigment epithelium 58 and the active electrode 13a (or 13b) faces the incident light.
  • endolaserphtocoagulation or endocautery burns 39 are made around the periphery of the device to secure the device.
  • the scar tissue so formed around the periphery of the device will prevent the device from moving out of position.
  • Endolaserphotocoagulation or endocautery 39 may also be used to seal the retinal incision.
  • Air or other approved gaseous compounds may also be injected into the vitreous cavity to tamponade the retinal opening during healing. The pars plana incision will be closed in the usual surgical manner.
  • An alternate method for implantation would involve making an incision through the sclera just posterior to the ora serata. Dissection would proceed through the choroid, choriocapillaris, Bruch's membrane and retinal pigment epithelium under stereo operating microscrope control into the potential space between the inner and outer retinal layers. The artificial retinal implant would then be inserted into this space and directed posteriorly towards the macula by a pushing action imparted by a formed curved iris spatula. The device will rest in the macula area of posterior pole of the eye between the inner and outer retinal layers.
  • the layers of the eye at the posterior pole from inside to outside are shown in FIG. 4: internal limiting membrane 40, nerve fiber layer 42, ganglion and amacrine cell layer 44, inner plexiform 46, inner nuclear layer 48, outer plexiform 50, outer nuclear and bipolar cell layer 52, and photoreceptor layer 54, all of which constitute the inner retinal layer 56.
  • the retinal pigment epithelium 58, and Bruch's membrane 60 constitute the outer retinal layer 62.
  • the choriocapillaris 64, and choroid 66 comprise the choroidal vasculature 68.
  • the outer coat of the eye is the sclera 70.
  • an amplitude-modulated current varying with illumination, produced by each photodiode of the device 10 will stimulate the overlying inner retinal layer consisting of photoreceptors (if present) and their cell bodies 54, 52, bipolar cells 48 and horizontal cells 52.
  • cells 48-52 normally both receive and produce analog amplitude-modulated currents, the analog amplitude-modulated output of the device is well suited for stimulation of these cells.
  • the amplitude-modulated signals of the bipolar cells 48 are then modified and converted by the amacrine and ganglion cells 44 to a frequency-modulated signal as is the normal biological event in the innermost area of the inner retinal layer for distant transmission through the optic nerve to the lateral geniculate area of the brain.
  • each photodiode will be automatically amplitude modulated corresponding to the intensity of the incident light
  • the resulting stimulation and signal current production of the overlying photoreceptor or bipolar cell layer will also be amplitude modulated thereby duplicating the normal amplitude-modulated character of these cells.
  • Stimulating inner retina 56 at the above indicated location will also allow the normal function of the horizontal cell on-off receptor fields thereby allowing contrast appreciation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Prostheses (AREA)

Abstract

A silicon chip device composed of a large array of densely packed microphotodiodes is implanted between the inner and outer retina layers, in patients with vision-deficient eyes suffering from retinal dysfunction, to allow for useful formed vision. The photoactive surface of each photodiode, with its silicon deposited or etched electrode, point towards the incident light. The device produces an amplitude-modulated current to stimulate the inner retinal layer. The device is intrinsically inert due to its doped silicon substrate nature.

Description

BACKGROUND OF THE INVENTION
The present invention is directed to a medical product and operation procedure which can be used to correct vision loss or even complete blindness caused by certain retinal diseases. A variety of retinal diseases, for example, cause vision loss or blindness by destruction of the choroid, choriocapillaris, and the outer retinal layers. The outer layers include Bruch's membrane and retinal pigment epithelium, the loss of which results in degeneration of the inner retinal photoreceptor layer. These diseases, however, often spare much of the remaining inner retinal layers of the outer nuclear, outer plexiform, inner nuclear, inner plexiform, ganglion cell and nerve fiber layers.
The current invention involves the use of an electronic device, a photosensitive array, that is capable of mimicking the signals that would otherwise be produced by the damaged inner retinal photoreceptor layer. When the device is implanted between the inner and outer retinal layers, it will stimulate the inner layer to provide significantly useful formed vision to a patient in a manner never before available.
Prior attempts have been made to produce vision by stimulating various portions of the retina. One such attempt involved an externally powered but internally located photosensitive array device with its photoactive surface and electrode surface on opposite sides. The device was to stimulate the nerve fiber layer via direct placement on this layer from the vitreous body side. The success of this device is unlikely due to it having to duplicate the complex frequency modulate neural signals of the nerve fiber layer. Furthermore, the nerve fiber layer runs in a general radial course with many layers of overlapping fibers from different portions of the retina making selection of the appropriate nerve fiber to stimulate extremely difficult if not impossible. The production of useful formed visual imagery is therefore highly unlikely. No device of this type has been known to have been constructed that produced any type of formed image.
Another prior device involved a unit consisting of a supporting base onto which a photo-sensitive material such as selenium is coated. This device was to have been inserted through an external scleral incision made at the posterior pole resting between the sclera and choroid or between the choroid and retina. Light simulation would then cause a potential to develop on the photosensitive surface causing ions to be produced which would then theoretically migrate into the retina causing stimulation. However, having no discrete surface structure to restrict the directional flow of charges, lateral migration and diffusion of charges would be allowed thereby preventing any resolution capability. Placement of this device between the sclera and choroid would also virtually block the discrete migration of ions to the photoreceptor and inner retinal layers due to the presence of the choroid, choriocapillaris, Bruch's membrane and the retinal pigment epithelial layer. Placement of the device between the choroid and the retina would still interpose Bruch's membrane and the retinal pigment epithelial layer in the pathway of discrete ion migration. Also, as this device would have had to be inserted into or through the highly vascular choroid of the posterior pole, severe subchoroidal, intraretinal and or intraorbital hemorrhage would likely have resulted along with disruption of blood flow to the posterior pole. One such device was apparently constructed and implanted into a patient's eye resulting in reported light perception but no formed imagery.
SUMMARY OF THE INVENTION
The artificial retina device of this invention circumvents the limitations of previous devices. It is composed of a plurality of discrete photodiodes with their individual electrodes disposed on one surface of a substrate, the photodiodes each being connected to a common electrical ground on the other side of the substrate. Each photodiode includes an active electrode layer overlaying a photosensitive layer, and each is connected to an electrical ground. The photodiodes have electrical outputs that correspond to the amplitude of the light incident on said device, whereby said device can be implanted in the eye intermediate the inner retinal layer and the retinal pigment epithelium of outer layer of the retina, so that each of said photodiodes will stimulate directly individual or small groups of cells in the inner retinal layer corresponding to the light incident on said device.
When inserted within the retina between the inner and outer retinal layers, in the potential space zone, an amplitude-modulated electric potential, varying with illumination, produced by each photodiode will stimulate the overlying inner retinal layer consisting of photoreceptors, bipolar cells and horizontal cells. As these cells normally both receive and produce analog amplitude-modulated currents, the analog amplitude-modulated output of the device is well suited for stimulation of these cells. The amplitude-modulated signals of the bipolar cells are then modified and converted by the amacrine and ganglion cells to a frequency-modulated signal as is the normal biological event in the innermost area of the inner retinal layer for distant transmission through the optic nerve to the lateral geniculate area of the brain. Because the complex conversion of the amplitude-modulated signal to the frequency-modulated signal is left to intrinsic retinal mechanisms, the formed vision produced is much enhanced compared to devices that attempt to stimulate the nerve fiber layer directly with electronic and amplifier reconstructed frequency-modulated signals.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1A is a perspective view of an artificial retina device of the present invention;
FIG. 1B is a perspective view of an alternative form of an artificial retina device of the present invention;
FIG. 1C (1)-(4) are perspective views of four alternative embodiments of the present invention;
FIG. 2A is a perspective, cross-sectional view of a first photodiode array for use in an artificial retina device of the present invention;
FIG. 2B is a perspective, cross-sectional view of a second photodiode array for use in an artificial retina device of the present invention;
FIG. 3A-3C illustrate steps in a surgical procedure for implanting an artificial retina device of the present invention; and
FIG. 4 is an exploded, cross-sectional view of an artificial retinal device of the present invention as implanted in the eye.
DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
In one embodiment of this invention, an artificial retina device 10 is generally circular in shape with an integral grasping member (FIG. 1B) or a projecting grasping member (FIG. 1A) to grasp the device while it is being inserted. The device ranges from 3 mm to 20 mm in diameter and from 0.005 mm to 2 mm in thickness.
As shown in FIG. 1C, the device 10 may be round (FIG. 1C (3)), oval (FIG. 1C (4)) elliptical (FIG. 1C (2)), or irregular (FIG. 1C (1)) in shape. The surface contours may be flat or curved to match the curvature of the retina. The edges or selected areas of the anterior 14 or posterior 16 (FIG. 2A) surfaces may be fashioned with ridges or other protrusions to improve stability within the retina and to improve biological acceptability. The device may also have ledges, lips or loops to aid manipulation during implantation. In addition, it may also have openings (not shown) between the two surfaces to allow passage of intraretinal nourishment and tissue ingrowth to maintain the device securely in the retina.
As shown in FIGS. 2A and 2B, the details of the photodiode construction of the artificial retina device of the present invention consist of multiple layers of both pure and doped silicon deposited and etched. An insulated or noninsulated polysilicon active electrode structure 13a projects from the surface in one embodiment (FIG. 2A), or a flat polysilicon active electrode surface 13b is constructed in another alternative embodiment (FIG. 2B) to transfer a current from the photodiode to the overlying photoreceptor, bipolar and inner retinal cell layers as explained in detail below. In particular, the polysilicon electrode structure 13a or 13b can be made by standard semiconductor plasma and/or wet etch techniques.
The artificial retina device of the present invention is, therefore, a large array of photovoltaic microphotodiodes of the PiN type. Each microphotodiode consists of a shallow P-doped photoactive layer 18 overlaying an intrinsic layer 20 which in turn overlays a N-doped layer 6. On the posterior surface of layer 6 is deposited a conductive layer 22 of polysilicon that forms the common complimentary electrode or ground. A common complimentary electrode is shown, but the device can be constructed with a discrete complimentary electrode for each microphotodiode.
On the anterior surface is deposited a layer of silicon nitrate 24 covering the entire surface except for openings (or on the unmasked areas) 26 that establish electrode contact areas for the polysilicon active electrode 13a (or 13b). The PiN layers may be reversed (NIP) or modified to facilitate reversal of the device polarity. As can be seen in FIGS. 2A and 2B, a plurality of nodes 28 are formed from a plurality of microphotodiodes described above. The designed current output of each self-powered photodiode node is on the order of 50 nA when the device is exposed to average room lighting. However, the electrical current output may be designed to be greater or less than this value depending upon the stimulation requirement of the overlying cell layer. A supplemental bias activation current may also be provided by an insulated wire or series of insulated wires leading from the device from the eye into an external or internally implanted battery unit.
As shown in FIG. 3A, the device 10 of this invention is inserted into the vitreous cavity of the eye 30 via a pars plana incision 32. A horizontal incision 34 (FIG. 3B) is then made through the retina from the vitreous side in the temporal portion of the posterior pole into the potential space between the photoreceptor layer and the retinal pigment epithelium. A horizontal incision 34 made at this location will avoid cutting inner retinal vasculature and will be parallel to coursing nerve fiber layers 36, therefore, also avoiding their injury. Illumination for the surgical procedure is provided by a optical fiber light pipe 38. The potential space is then be opened by canula irrigation of a balanced salt solution into the intraretinal space.
The device is then placed into the intraretinal cavity (FIG. 3C) at the posterior pole under the macula area. Specifically, the device is placed between the retinal pigment epithelium 58 (FIG. 4) and photoreceptor layer 54, or if photoreceptor layer 54 is atrophied or lost then between the retinal pigment epithelium 58 and the bipolar and horizontal cell layer 52. The device is positioned such that the electrical ground 22 is overlaying the retinal pigment epithelium 58 and the active electrode 13a (or 13b) faces the incident light.
After insertion, a series of endolaserphtocoagulation or endocautery burns 39 are made around the periphery of the device to secure the device. The scar tissue so formed around the periphery of the device will prevent the device from moving out of position. Endolaserphotocoagulation or endocautery 39 may also be used to seal the retinal incision. Air or other approved gaseous compounds may also be injected into the vitreous cavity to tamponade the retinal opening during healing. The pars plana incision will be closed in the usual surgical manner.
An alternate method for implantation would involve making an incision through the sclera just posterior to the ora serata. Dissection would proceed through the choroid, choriocapillaris, Bruch's membrane and retinal pigment epithelium under stereo operating microscrope control into the potential space between the inner and outer retinal layers. The artificial retinal implant would then be inserted into this space and directed posteriorly towards the macula by a pushing action imparted by a formed curved iris spatula. The device will rest in the macula area of posterior pole of the eye between the inner and outer retinal layers.
The layers of the eye at the posterior pole from inside to outside are shown in FIG. 4: internal limiting membrane 40, nerve fiber layer 42, ganglion and amacrine cell layer 44, inner plexiform 46, inner nuclear layer 48, outer plexiform 50, outer nuclear and bipolar cell layer 52, and photoreceptor layer 54, all of which constitute the inner retinal layer 56. The retinal pigment epithelium 58, and Bruch's membrane 60 constitute the outer retinal layer 62. The choriocapillaris 64, and choroid 66 comprise the choroidal vasculature 68. The outer coat of the eye is the sclera 70.
With regard to FIG. 4, when the device 10 is inserted within the retina between the inner retinal layer 56 (that may or may not contain a functional photoreceptor layer 54) and the outer retinal layer 62, in the potential space zone 72, an amplitude-modulated current varying with illumination, produced by each photodiode of the device 10 will stimulate the overlying inner retinal layer consisting of photoreceptors (if present) and their cell bodies 54, 52, bipolar cells 48 and horizontal cells 52. As cells 48-52 normally both receive and produce analog amplitude-modulated currents, the analog amplitude-modulated output of the device is well suited for stimulation of these cells. The amplitude-modulated signals of the bipolar cells 48 are then modified and converted by the amacrine and ganglion cells 44 to a frequency-modulated signal as is the normal biological event in the innermost area of the inner retinal layer for distant transmission through the optic nerve to the lateral geniculate area of the brain.
As the output of each photodiode will be automatically amplitude modulated corresponding to the intensity of the incident light, the resulting stimulation and signal current production of the overlying photoreceptor or bipolar cell layer will also be amplitude modulated thereby duplicating the normal amplitude-modulated character of these cells. Stimulating inner retina 56 at the above indicated location will also allow the normal function of the horizontal cell on-off receptor fields thereby allowing contrast appreciation.
Although recognizable color information output may not occur from the stimulated cells, significant formed vision output should develop serving as input for the amacrine and ganglion cell layers which will modify the signal into a frequency modulated signal for transmission to the lateral geniculate area of the brain.
While several embodiments of this invention are described, others will be apparent to those of ordinary skill in the art. Such other embodiments are to be included within the scope of the present invention, unless the claims that follow expressly state otherwise.

Claims (15)

I claim:
1. An artificial retina device, comprising: a plurality of discrete photodiodes disposed on one surface of a substrate, said photodiodes each including an active electrode layer overlaying a photosensitive layer, each photodiode being connected to an electrical ground, said photodiodes having electrical outputs that correspond to the amplitude of the light incident on said device, whereby said device can be implanted in the eye intermediate the inner retinal layer and the retinal pigment epithelium of outer layer of the retina, so that each of said photodiodes will stimulate directly individual or small groups of cells in the inner retinal layer corresponding to the light incident on said device.
2. The artificial retina device of claim 1, wherein said device is from 3 mm to 20 mm in its maximum width, and from 0.005 mm to 2 mm between said two surfaces.
3. The artificial retina device of claim 1 that further includes a grasping member.
4. The artificial retina device of claim 1 further including a plurality of openings between said two surfaces.
5. The artificial retina device of claim 1 wherein one or both surfaces are curved.
6. The retinal implant device of claim 1, wherein said first surface includes a plurality of protuberances that extend therefrom.
7. The retinal implant device of claim 1, wherein said first surface is flat.
8. The retinal implant device of claim 1 wherein said photosensitive layer comprises a P-doped layer, and said device further includes an intrinsic layer and a N-doped layer, said intrinsic layer being disposed between said P-doped layer and said N-doped layer.
9. The retinal implant device of claim 1 wherein said photosensitive layer comprises a N-doped layer and said device further includes an intrinsic layer and a P-doped layer, said intrinsic layer being disposed between said N-doped layer and said P-doped layer.
10. The retinal implant device of claim 8 wherein said active electrode is formed from polysilicon.
11. The retinal implant device of claim 9 wherein said active electrode is formed from polysilicon.
12. A surgical procedure for implanting a device of claim 1, comprising
making a horizontal incision temporal to the macula, parallel to and through the nerve fiber layer;
opening the potential space within the retina by irrigating with balanced salt solution;
inserting said device into said space intermediate the inner retinal layer and the retinal pigment epithelium of outer layer of the retina with said photodiodes facing light incident into said eye;
and closing said incision and space.
13. The surgical procedure of claim 12 wherein a plurality of burns are made around the periphery of said device to secure the device in position.
14. A method for producing artificial vision, comprising:
making an incision through the sclera posterior to the ora serata, through the choroidal vasculature, the outer retinal layer and into the potential space between the inner and outer retinal layer; and
inserting a device of claim 1 into said space whereby it is positioned in the macula area of the posterior pole of the eye.
15. A method for producing artificial vision, comprising: implanting a device of claim 1 into the potential space of the retina between the retinal pigment epithelium and the inner retinal layer with the active electrode facing light incident the eye, whereby said device intercepts light after its passage through the nerve fiber layer and inner retinal layers of the eye, and produces discrete stimulation from inside the retina of bipolar cells, horizontal cells, amacrine cells and ganglion cells.
US07/390,562 1989-08-08 1989-08-08 Artificial retina device Expired - Lifetime US5016633A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US07/390,562 US5016633A (en) 1989-08-08 1989-08-08 Artificial retina device
US07/549,094 US5024223A (en) 1989-08-08 1990-07-06 Artificial retina device
CA002022544A CA2022544C (en) 1989-08-08 1990-08-02 Artificial retina device
ES90308575T ES2110410T3 (en) 1989-08-08 1990-08-03 ARTIFICIAL RETINA DEVICE.
EP90308575A EP0460320B1 (en) 1989-08-08 1990-08-03 Artificial retina device
DE69031908T DE69031908T2 (en) 1989-08-08 1990-08-03 Artificial retina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/390,562 US5016633A (en) 1989-08-08 1989-08-08 Artificial retina device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US07/549,094 Continuation-In-Part US5024223A (en) 1989-08-08 1990-07-06 Artificial retina device

Publications (1)

Publication Number Publication Date
US5016633A true US5016633A (en) 1991-05-21

Family

ID=23542978

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/390,562 Expired - Lifetime US5016633A (en) 1989-08-08 1989-08-08 Artificial retina device

Country Status (1)

Country Link
US (1) US5016633A (en)

Cited By (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159927A (en) * 1989-07-26 1992-11-03 Ferdinand Schmid Visual prosthesis apparatus and method
US5397350A (en) * 1993-05-03 1995-03-14 Chow; Alan Y. Independent photoelectric artificial retina device and method of using same
US5476494A (en) * 1992-09-11 1995-12-19 Massachusetts Institute Of Technology Low pressure neural contact structure
DE4424753A1 (en) * 1994-07-13 1996-01-18 Fraunhofer Ges Forschung Retina implant with array of polymer-sheathed conductive filaments on insulating substrate
US5556423A (en) * 1993-05-03 1996-09-17 Alan Y. Chow Independent photoelectric artificial retina device and method of using same
US5597381A (en) * 1993-06-03 1997-01-28 Massachusetts Eye And Ear Infirmary Methods for epi-retinal implantation
US5873901A (en) * 1995-06-30 1999-02-23 Space Vacuum Epitaxy Center University Of Houston Treating retinal damage by implanting thin film optical detectors
US5895415A (en) * 1995-06-06 1999-04-20 Optobionics Corporation Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US5935155A (en) * 1998-03-13 1999-08-10 John Hopkins University, School Of Medicine Visual prosthesis and method of using same
US5944747A (en) * 1998-03-13 1999-08-31 Johns Hopkins University Method for preferential outer retinal stimulation
US6032062A (en) * 1995-08-10 2000-02-29 Nmi Naturwissenschaftliches Und Medizinisches Institut Microelectrode arrangement
WO2000056393A1 (en) 1999-03-24 2000-09-28 Second Sight, Llc Retinal color prosthesis for color sight restoration
WO2000056244A2 (en) 1999-03-24 2000-09-28 Second Sight, Llc Logarithmic light intensifier for use with photoreceptor-based implanted retinal prosthetics and those prosthetics
US6230057B1 (en) 1995-06-06 2001-05-08 Optobionics Corporation Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US6324429B1 (en) * 1998-05-08 2001-11-27 Massachusetts Eye And Ear Infirmary Chronically implantable retinal prosthesis
US6389317B1 (en) 2000-03-31 2002-05-14 Optobionics Corporation Multi-phasic microphotodetector retinal implant with variable voltage and current capability
WO2002080816A1 (en) * 2001-03-30 2002-10-17 Nagoya Ind Science Reserach I Electrode member for retinal stimulation, and artificial retinal device using the electrode member
US20020169486A1 (en) * 2000-05-04 2002-11-14 Optobionics Corporation Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
WO2003002070A2 (en) 2001-06-29 2003-01-09 Optobionics Corporation Methods for improving damaged retinal cell function using physical and/or mechanical stimulation
DE10151650A1 (en) * 2001-10-17 2003-05-08 Univ Eberhard Karls Electrode arrangement for electrical stimulation of biological material and multi-electrode array for use in such
US20030097166A1 (en) * 2001-11-16 2003-05-22 The Regents Of The University Of California Flexible electrode array for artifical vision
US20030158588A1 (en) * 2002-01-17 2003-08-21 Rizzo Joseph F. Minimally invasive retinal prosthesis
US20030187491A1 (en) * 2002-03-28 2003-10-02 Robert Greenberg Variable pitch electrode array
WO2004075005A2 (en) * 2003-02-14 2004-09-02 The Board Of Trustees Of The Leland Stanford Junior University Neural prosthesis based on photomechanical deflectors and tactile sensory cells
US20040236389A1 (en) * 2003-05-01 2004-11-25 Wolfgang Fink Method and system for training a visual prosthesis
US20050004625A1 (en) * 2001-06-29 2005-01-06 Chow Alan Y. Treatment of degenerative retinal disease via electrical stimulation of surface structures
US20050010266A1 (en) * 2003-03-24 2005-01-13 Les Bogdanowicz Device and methodology for ocular stimulation
US20050033202A1 (en) * 2001-06-29 2005-02-10 Chow Alan Y. Mechanically activated objects for treatment of degenerative retinal disease
US20050062679A1 (en) * 2002-12-17 2005-03-24 Visioncare Ophthalmic Technologies Inc. Intraocular implants
EP1618922A1 (en) * 2004-07-23 2006-01-25 Nidek Co., Ltd. Visual restoration aiding device
US7037943B2 (en) 2001-04-10 2006-05-02 Optobionics Corporation Retinal treatment method
US20060148254A1 (en) * 2005-01-05 2006-07-06 Mclean George Y Activated iridium oxide electrodes and methods for their fabrication
US7088387B1 (en) * 1997-08-05 2006-08-08 Mitsubishi Electric Research Laboratories, Inc. Video recording device responsive to triggering event
US7127301B1 (en) 2003-04-28 2006-10-24 Sandia Corporation Flexible retinal electrode array
US20070049987A1 (en) * 2003-03-21 2007-03-01 Greenberg Robert J Trans-retinal flexible circuit electrode array
EP1762269A2 (en) 1999-03-24 2007-03-14 Second Sight Medical Products, Inc. Visual prothesis
US20070073359A1 (en) * 2005-09-16 2007-03-29 Mcclure Kelly H Downloadable filters for a visual prosthesis
US20070191909A1 (en) * 2006-02-15 2007-08-16 Doheny Eye Institute Wide-field retinal prosthesis
EP1864690A2 (en) 1999-03-24 2007-12-12 Second Sight Medical Products, Inc. Logarithmic light intensifier for use with photoreceptorbased implanted retinal prosthetics and those prosthetics
US20080046080A1 (en) * 2006-07-07 2008-02-21 Interuniversitair Microelektronica Centrum (Imec) Method for forming packaged microelectronic devices and devices thus obtained
US20080066500A1 (en) * 2006-09-15 2008-03-20 Shun-Chang Su Cable lock that is opened forcibly
US20080228242A1 (en) * 2003-05-01 2008-09-18 California Institute Of Technology Method and system for training a visual prosthesis
US20100204754A1 (en) * 2009-02-09 2010-08-12 Rainbow Medical Ltd. Retinal prosthesis
US20100241060A1 (en) * 2009-03-18 2010-09-23 Roizman Keith Surgical devices and methods
CN101853862A (en) * 2010-04-29 2010-10-06 北京大学 Photoelectric microelectrode array used for artificial retina and manufacturing method thereof
US20110172736A1 (en) * 2010-01-14 2011-07-14 Nano-Retina, Inc. Penetrating electrodes for retinal stimulation
US8180453B2 (en) 1999-03-24 2012-05-15 Second Sight Medical Products, Inc. Electrode array for neural stimulation
US8428740B2 (en) 2010-08-06 2013-04-23 Nano-Retina, Inc. Retinal prosthesis techniques
US8442641B2 (en) 2010-08-06 2013-05-14 Nano-Retina, Inc. Retinal prosthesis techniques
US8478415B1 (en) * 2004-11-19 2013-07-02 National Semiconductor Corporation Heat transfer control for a prosthetic retinal device
US8571669B2 (en) 2011-02-24 2013-10-29 Nano-Retina, Inc. Retinal prosthesis with efficient processing circuits
US8706243B2 (en) 2009-02-09 2014-04-22 Rainbow Medical Ltd. Retinal prosthesis techniques
US8712542B2 (en) 2008-11-04 2014-04-29 Boston Scientific Neuromodulation Corporation Deposited conductive layers for leads of implantable electric stimulation systems and methods of making and using
US20150246220A1 (en) * 2012-05-09 2015-09-03 Po-Kang Lin Structure of Artificial Electronic Retina
US9331791B2 (en) 2014-01-21 2016-05-03 Nano Retina Ltd. Transfer of power and data
US9370417B2 (en) 2013-03-14 2016-06-21 Nano-Retina, Inc. Foveated retinal prosthesis
US9474902B2 (en) 2013-12-31 2016-10-25 Nano Retina Ltd. Wearable apparatus for delivery of power to a retinal prosthesis
EP3461529A1 (en) 2017-09-27 2019-04-03 Pixium Vision SA Tip, inserter attachment and delivery device
CN109711286A (en) * 2018-12-11 2019-05-03 中国科学院深圳先进技术研究院 A kind of control method and device based on artificial retina spatial perception
CN109701157A (en) * 2017-12-29 2019-05-03 深圳硅基仿生科技有限公司 Radio-frequency signal detection device and retina stimulator with detection coil
CN110740776A (en) * 2017-03-23 2020-01-31 高丽大学校产学协力团 Artificial retinal system for improving contrast sensitivity
CN115376391A (en) * 2022-08-19 2022-11-22 中国科学技术大学苏州高等研究院 Three-dimensional eyeball imitation body and preparation method and application thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2760483A (en) * 1953-10-29 1956-08-28 Tassicker Graham Edward Retinal stimulator
US3594823A (en) * 1969-02-11 1971-07-27 Patent Management Inc Visual substitution system with receptor scanning means
US3628193A (en) * 1969-02-19 1971-12-21 Inst Of Medical Sciences The Tactile image projection system
US3766311A (en) * 1972-04-26 1973-10-16 H Boll Sensory substitution system
US3848608A (en) * 1973-07-23 1974-11-19 Gen Electric Subject integument spatial stimulator
US3914800A (en) * 1974-06-06 1975-10-28 Inst Of Medical Sciences Fluid mechanical tactile oscilloscope to augment the five senses
US4272910A (en) * 1979-07-31 1981-06-16 Danz W R Ocular prosthetic or the like
US4551149A (en) * 1982-02-16 1985-11-05 Michael Sciarra Prosthetic vision system
US4601545A (en) * 1984-05-16 1986-07-22 Kern Seymour P Variable power lens system
US4628933A (en) * 1985-07-23 1986-12-16 Michelson Robin P Method and apparatus for visual prosthesis

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2760483A (en) * 1953-10-29 1956-08-28 Tassicker Graham Edward Retinal stimulator
US3594823A (en) * 1969-02-11 1971-07-27 Patent Management Inc Visual substitution system with receptor scanning means
US3628193A (en) * 1969-02-19 1971-12-21 Inst Of Medical Sciences The Tactile image projection system
US3766311A (en) * 1972-04-26 1973-10-16 H Boll Sensory substitution system
US3848608A (en) * 1973-07-23 1974-11-19 Gen Electric Subject integument spatial stimulator
US3914800A (en) * 1974-06-06 1975-10-28 Inst Of Medical Sciences Fluid mechanical tactile oscilloscope to augment the five senses
US4272910A (en) * 1979-07-31 1981-06-16 Danz W R Ocular prosthetic or the like
US4551149A (en) * 1982-02-16 1985-11-05 Michael Sciarra Prosthetic vision system
US4601545A (en) * 1984-05-16 1986-07-22 Kern Seymour P Variable power lens system
US4628933A (en) * 1985-07-23 1986-12-16 Michelson Robin P Method and apparatus for visual prosthesis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Science News, Feb. 2, 1974, vol. 105, No. 5, p. 105. *
Science, Jul., 1981. *

Cited By (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159927A (en) * 1989-07-26 1992-11-03 Ferdinand Schmid Visual prosthesis apparatus and method
US5476494A (en) * 1992-09-11 1995-12-19 Massachusetts Institute Of Technology Low pressure neural contact structure
US5397350A (en) * 1993-05-03 1995-03-14 Chow; Alan Y. Independent photoelectric artificial retina device and method of using same
JP3529780B2 (en) 1993-05-03 2004-05-24 アレン ワイ チョー Independent photoelectric subretinal implant
US5556423A (en) * 1993-05-03 1996-09-17 Alan Y. Chow Independent photoelectric artificial retina device and method of using same
US5597381A (en) * 1993-06-03 1997-01-28 Massachusetts Eye And Ear Infirmary Methods for epi-retinal implantation
DE4424753B4 (en) * 1994-07-13 2004-07-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Retinal implant
DE4424753A1 (en) * 1994-07-13 1996-01-18 Fraunhofer Ges Forschung Retina implant with array of polymer-sheathed conductive filaments on insulating substrate
US20020087202A1 (en) * 1995-06-06 2002-07-04 Optobionics Corportion Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US7139612B2 (en) 1995-06-06 2006-11-21 Optobionics Corporation Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US6230057B1 (en) 1995-06-06 2001-05-08 Optobionics Corporation Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US6611716B2 (en) * 1995-06-06 2003-08-26 Optobionics Corporation Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US5895415A (en) * 1995-06-06 1999-04-20 Optobionics Corporation Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US20040088026A1 (en) * 1995-06-06 2004-05-06 Optobionics Corporation Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
JP3514464B2 (en) 1995-06-06 2004-03-31 ビンセント チョウ Multiphase microphotodiode retinal implant and corresponding imaging retinal stimulation system
US5873901A (en) * 1995-06-30 1999-02-23 Space Vacuum Epitaxy Center University Of Houston Treating retinal damage by implanting thin film optical detectors
US6032062A (en) * 1995-08-10 2000-02-29 Nmi Naturwissenschaftliches Und Medizinisches Institut Microelectrode arrangement
US7088387B1 (en) * 1997-08-05 2006-08-08 Mitsubishi Electric Research Laboratories, Inc. Video recording device responsive to triggering event
US5944747A (en) * 1998-03-13 1999-08-31 Johns Hopkins University Method for preferential outer retinal stimulation
US5935155A (en) * 1998-03-13 1999-08-10 John Hopkins University, School Of Medicine Visual prosthesis and method of using same
US6324429B1 (en) * 1998-05-08 2001-11-27 Massachusetts Eye And Ear Infirmary Chronically implantable retinal prosthesis
US20080275528A1 (en) * 1999-03-24 2008-11-06 Greenberg Robert J Electrode Array for Visual Stimulation
US20080077195A1 (en) * 1999-03-24 2008-03-27 Greenberg Robert J Package for an Implantable Device
US7725191B2 (en) 1999-03-24 2010-05-25 Second Sight Medical Products, Inc. Package for an implantable device
US7894911B2 (en) 1999-03-24 2011-02-22 Second Sight Medical Products, Inc. Electrode array for neural stimulation
EP2275166A2 (en) 1999-03-24 2011-01-19 Second Sight Medical Products, Inc. Visual prosthesis
US20090204212A1 (en) * 1999-03-24 2009-08-13 Greenberg Robert J Logarithmic Light Intensifier for use with Photoreceptor-Based Implanted Retinal Prosthetics and those Prosthetics
WO2000056393A1 (en) 1999-03-24 2000-09-28 Second Sight, Llc Retinal color prosthesis for color sight restoration
US8046078B2 (en) 1999-03-24 2011-10-25 Second Sight Medical Products, Inc. Logarithmic light intensifier for use with photoreceptor-based implanted retinal prosthetics and those prosthetics
US8131378B2 (en) 1999-03-24 2012-03-06 Second Sight Medical Products, Inc. Inductive repeater coil for an implantable device
WO2000056244A2 (en) 1999-03-24 2000-09-28 Second Sight, Llc Logarithmic light intensifier for use with photoreceptor-based implanted retinal prosthetics and those prosthetics
US8170676B2 (en) 1999-03-24 2012-05-01 Second Sight Medical Products, Inc. Electrode array
US20070016294A1 (en) * 1999-03-24 2007-01-18 Greenberg Robert J Logarithmic light intensifier for use with photoreceptor-based implanted retinal prosthetics and those prosthetics
US6507758B1 (en) 1999-03-24 2003-01-14 Second Sight, Llc Logarithmic light intensifier for use with photoreceptor-based implanted retinal prosthetics and those prosthetics
EP1864690A2 (en) 1999-03-24 2007-12-12 Second Sight Medical Products, Inc. Logarithmic light intensifier for use with photoreceptorbased implanted retinal prosthetics and those prosthetics
US8090448B2 (en) 1999-03-24 2012-01-03 Second Sight Medical Products, Inc. Low profile package for an implantable device
US7257446B2 (en) 1999-03-24 2007-08-14 Second Sight Medical Products, Inc. Package for an implantable medical device
US7957810B2 (en) 1999-03-24 2011-06-07 Second Sight Medical Products, Inc. Motion compensation for a visual prosthesis
US8355800B2 (en) 1999-03-24 2013-01-15 Second Sight Medical Products, Inc. Coating package for an implantable device
US20060036296A1 (en) * 1999-03-24 2006-02-16 Greenberg Robert J Electrode array for neural stimulation
US7835798B2 (en) 1999-03-24 2010-11-16 Second Sight Medical Products, Inc. Electrode array for visual stimulation
US7840274B2 (en) 1999-03-24 2010-11-23 Second Sight Medical Products, Inc. Visual color prosthesis
US20080097555A1 (en) * 1999-03-24 2008-04-24 Greenberg Robert J Inductive Repeater Coil for an Implantable Device
US8180453B2 (en) 1999-03-24 2012-05-15 Second Sight Medical Products, Inc. Electrode array for neural stimulation
EP2275167A2 (en) 1999-03-24 2011-01-19 Second Sight Medical Products, Inc. Visual prosthesis
US20080077196A1 (en) * 1999-03-24 2008-03-27 Greenberg Robert J Motion Compensation for a Visual Prosthesis
US20090005835A1 (en) * 1999-03-24 2009-01-01 Greenberg Robert J Low Profile Package for an Implantable Device
EP1762269A2 (en) 1999-03-24 2007-03-14 Second Sight Medical Products, Inc. Visual prothesis
US7539544B2 (en) 1999-03-24 2009-05-26 Second Sight Medical Products, Inc. Logarithmic light intensifier for use with photoreceptor-based implanted retinal prosthetics and those prosthetics
US7006873B2 (en) 2000-03-31 2006-02-28 Optobionics Corporation Adjustment of electrical stimulus in a retinal implant
US6389317B1 (en) 2000-03-31 2002-05-14 Optobionics Corporation Multi-phasic microphotodetector retinal implant with variable voltage and current capability
EP1267991A1 (en) * 2000-03-31 2003-01-02 Optobionics Corporation Multi-phasic microphotodetector retinal implant with variable voltage and current capability and apparatus for insertion
EP1267991A4 (en) * 2000-03-31 2005-08-31 Optobionics Corp Multi-phasic microphotodetector retinal implant with variable voltage and current capability and apparatus for insertion
US20040082981A1 (en) * 2000-03-31 2004-04-29 Optobionics Corporation Multi-phasic microphotodetector retinal implant with variable voltage and current capability and apparatus for insertion
US20060142857A1 (en) * 2000-05-04 2006-06-29 Optobionics Corporation Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
US7003354B2 (en) 2000-05-04 2006-02-21 Optobionics Corporation Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
US20020169486A1 (en) * 2000-05-04 2002-11-14 Optobionics Corporation Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
US8306626B2 (en) 2000-05-04 2012-11-06 Imi Intelligent Medical Implants Ag Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
US7979134B2 (en) * 2000-05-04 2011-07-12 Imi Intelligent Medical Implants Ag Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
US20110238134A1 (en) * 2000-05-04 2011-09-29 Imi Intelligent Medical Implants Ag Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
WO2002080816A1 (en) * 2001-03-30 2002-10-17 Nagoya Ind Science Reserach I Electrode member for retinal stimulation, and artificial retinal device using the electrode member
US7158836B2 (en) 2001-03-30 2007-01-02 Satoshi Suzuki Electrode member for retinal stimulation, and artificial retinal device using the electrode member
US7037943B2 (en) 2001-04-10 2006-05-02 Optobionics Corporation Retinal treatment method
US20050004625A1 (en) * 2001-06-29 2005-01-06 Chow Alan Y. Treatment of degenerative retinal disease via electrical stimulation of surface structures
US20060142818A1 (en) * 2001-06-29 2006-06-29 Optobionics Methods for improving damaged retinal cell function
US7031776B2 (en) 2001-06-29 2006-04-18 Optobionics Methods for improving damaged retinal cell function
EP1409072A4 (en) * 2001-06-29 2005-12-21 Optobionics Corp Methods for improving damaged retinal cell function using physical and/or mechanical stimulation
US20050033202A1 (en) * 2001-06-29 2005-02-10 Chow Alan Y. Mechanically activated objects for treatment of degenerative retinal disease
EP1409072A2 (en) * 2001-06-29 2004-04-21 Optobionics Corporation Methods for improving damaged retinal cell function using physical and/or mechanical stimulation
US20100121231A1 (en) * 2001-06-29 2010-05-13 Chow Alan Y Mechanically activated objects for treatment of degenerative retinal disease
US7981062B2 (en) 2001-06-29 2011-07-19 Imi Intelligent Medical Implants Ag Mechanically activated objects for treatment of degenerative retinal disease
WO2003002070A2 (en) 2001-06-29 2003-01-09 Optobionics Corporation Methods for improving damaged retinal cell function using physical and/or mechanical stimulation
US20040267344A1 (en) * 2001-10-17 2004-12-30 Alfred Stett Electrode arrangement for electrical stimulation of biological material, and a multi-electrode array for use in such an electrode arrangement
US7272447B2 (en) 2001-10-17 2007-09-18 Retina Implant Gmbh Electrode arrangement for electrical stimulation of biological material, and a multi-electrode array for use in such an electrode arrangement
DE10151650A1 (en) * 2001-10-17 2003-05-08 Univ Eberhard Karls Electrode arrangement for electrical stimulation of biological material and multi-electrode array for use in such
US20030097166A1 (en) * 2001-11-16 2003-05-22 The Regents Of The University Of California Flexible electrode array for artifical vision
US7146221B2 (en) * 2001-11-16 2006-12-05 The Regents Of The University Of California Flexible electrode array for artifical vision
US6976998B2 (en) 2002-01-17 2005-12-20 Massachusetts Institute Of Technology Minimally invasive retinal prosthesis
US20030158588A1 (en) * 2002-01-17 2003-08-21 Rizzo Joseph F. Minimally invasive retinal prosthesis
US9089690B2 (en) 2002-03-28 2015-07-28 Second Sight Medical Products, Inc. Variable pitch electrode array
US7149586B2 (en) 2002-03-28 2006-12-12 Second Sight Medical Products, Inc. Variable pitch electrode array
US20090326623A1 (en) * 2002-03-28 2009-12-31 Robert Greenberg Variable pitch electrode array
US20030187491A1 (en) * 2002-03-28 2003-10-02 Robert Greenberg Variable pitch electrode array
US20050209691A1 (en) * 2002-12-17 2005-09-22 Visioncare Ophthalmic Technologies Inc. Intraocular implants
US7776087B2 (en) * 2002-12-17 2010-08-17 Visioncare Ophthalmic Technologies Inc. Intraocular implants
US20050062679A1 (en) * 2002-12-17 2005-03-24 Visioncare Ophthalmic Technologies Inc. Intraocular implants
US20050065602A1 (en) * 2002-12-17 2005-03-24 Visioncare Ophthalmic Technologies Inc. Intraocular implants
US20050154457A1 (en) * 2002-12-17 2005-07-14 Eli Aharoni Intraocular implants
US20050222680A1 (en) * 2002-12-17 2005-10-06 Visioncare Ophthalmic Technologies Inc. Intraocular implants
US7736390B2 (en) 2002-12-17 2010-06-15 Visioncare Ophthalmic Technologies Inc. Intraocular implants
US7727277B2 (en) 2002-12-17 2010-06-01 Visioncare Ophthalmic Technologies Inc. Intraocular implants
WO2004075005A3 (en) * 2003-02-14 2004-10-21 Univ Leland Stanford Junior Neural prosthesis based on photomechanical deflectors and tactile sensory cells
WO2004075005A2 (en) * 2003-02-14 2004-09-02 The Board Of Trustees Of The Leland Stanford Junior University Neural prosthesis based on photomechanical deflectors and tactile sensory cells
US8131375B2 (en) * 2003-03-21 2012-03-06 Second Sight Medical Products, Inc. Trans-retinal flexible circuit electrode array
US20080086183A1 (en) * 2003-03-21 2008-04-10 Greenberg Robert J Trans-Retinal Flexible Circuit Electrode Array
US20070049987A1 (en) * 2003-03-21 2007-03-01 Greenberg Robert J Trans-retinal flexible circuit electrode array
US8447410B2 (en) * 2003-03-21 2013-05-21 Second Sight Medical Products, Inc. Trans-retinal drug delivery device
US7321795B2 (en) 2003-03-24 2008-01-22 Les Bogdanowicz Compositions for electric stimulation of the eye
US20050010266A1 (en) * 2003-03-24 2005-01-13 Les Bogdanowicz Device and methodology for ocular stimulation
US7308317B1 (en) 2003-04-28 2007-12-11 Sandia Corporation Micromachined electrode array
US7127301B1 (en) 2003-04-28 2006-10-24 Sandia Corporation Flexible retinal electrode array
US20080228242A1 (en) * 2003-05-01 2008-09-18 California Institute Of Technology Method and system for training a visual prosthesis
US20040236389A1 (en) * 2003-05-01 2004-11-25 Wolfgang Fink Method and system for training a visual prosthesis
US8260428B2 (en) 2003-05-01 2012-09-04 California Institute Of Technology Method and system for training a visual prosthesis
US7321796B2 (en) 2003-05-01 2008-01-22 California Institute Of Technology Method and system for training a visual prosthesis
US20080154338A1 (en) * 2003-05-01 2008-06-26 Wolfgang Fink Method and system for training a visual prosthesis
US7403822B2 (en) 2004-07-23 2008-07-22 Nidek Co., Ltd. Visual restoration aiding device
EP1618922A1 (en) * 2004-07-23 2006-01-25 Nidek Co., Ltd. Visual restoration aiding device
US20060074461A1 (en) * 2004-07-23 2006-04-06 Nidek Co., Ltd. Visual restoration aiding device
US8478415B1 (en) * 2004-11-19 2013-07-02 National Semiconductor Corporation Heat transfer control for a prosthetic retinal device
US20060148254A1 (en) * 2005-01-05 2006-07-06 Mclean George Y Activated iridium oxide electrodes and methods for their fabrication
US20080046029A1 (en) * 2005-09-16 2008-02-21 Mcclure Kelly H Downloadable Filters for a Visual Prosthesis
US20070073359A1 (en) * 2005-09-16 2007-03-29 Mcclure Kelly H Downloadable filters for a visual prosthesis
US8224454B2 (en) * 2005-09-16 2012-07-17 Second Sight Medical Products, Inc. Downloadable filters for a visual prosthesis
US8571668B2 (en) * 2005-09-16 2013-10-29 Second Sight Medical Products, Inc. Downloadable filters for a visual prosthesis
US20070191909A1 (en) * 2006-02-15 2007-08-16 Doheny Eye Institute Wide-field retinal prosthesis
US8190266B2 (en) * 2006-02-15 2012-05-29 Dohey Eye Institute Wide-field retinal prosthesis
US20080046080A1 (en) * 2006-07-07 2008-02-21 Interuniversitair Microelektronica Centrum (Imec) Method for forming packaged microelectronic devices and devices thus obtained
US20080066500A1 (en) * 2006-09-15 2008-03-20 Shun-Chang Su Cable lock that is opened forcibly
US8712542B2 (en) 2008-11-04 2014-04-29 Boston Scientific Neuromodulation Corporation Deposited conductive layers for leads of implantable electric stimulation systems and methods of making and using
US9265945B2 (en) 2009-02-09 2016-02-23 Nano-Retina, Inc. Retinal prosthesis
US9907969B2 (en) 2009-02-09 2018-03-06 Nano-Retina, Inc. Retinal prosthesis with an external power source
US9566191B2 (en) 2009-02-09 2017-02-14 Nano-Retina, Inc. Retinal prosthesis with visible-light filter
US8150526B2 (en) 2009-02-09 2012-04-03 Nano-Retina, Inc. Retinal prosthesis
US20100204754A1 (en) * 2009-02-09 2010-08-12 Rainbow Medical Ltd. Retinal prosthesis
US9198753B2 (en) 2009-02-09 2015-12-01 Nano-Retina Inc. Techniques for powering a retinal prosthesis
US8706243B2 (en) 2009-02-09 2014-04-22 Rainbow Medical Ltd. Retinal prosthesis techniques
US20100241060A1 (en) * 2009-03-18 2010-09-23 Roizman Keith Surgical devices and methods
US8718784B2 (en) 2010-01-14 2014-05-06 Nano-Retina, Inc. Penetrating electrodes for retinal stimulation
US20110172736A1 (en) * 2010-01-14 2011-07-14 Nano-Retina, Inc. Penetrating electrodes for retinal stimulation
CN101853862A (en) * 2010-04-29 2010-10-06 北京大学 Photoelectric microelectrode array used for artificial retina and manufacturing method thereof
US8428740B2 (en) 2010-08-06 2013-04-23 Nano-Retina, Inc. Retinal prosthesis techniques
US8442641B2 (en) 2010-08-06 2013-05-14 Nano-Retina, Inc. Retinal prosthesis techniques
US9192464B2 (en) 2011-02-24 2015-11-24 Nano-Retina, Inc. Retinal prosthesis with efficient processing circuits
US8571669B2 (en) 2011-02-24 2013-10-29 Nano-Retina, Inc. Retinal prosthesis with efficient processing circuits
US20150246220A1 (en) * 2012-05-09 2015-09-03 Po-Kang Lin Structure of Artificial Electronic Retina
US9427569B2 (en) * 2012-05-09 2016-08-30 Po-Kang Lin Structure of artificial electronic retina
US9370417B2 (en) 2013-03-14 2016-06-21 Nano-Retina, Inc. Foveated retinal prosthesis
US9474902B2 (en) 2013-12-31 2016-10-25 Nano Retina Ltd. Wearable apparatus for delivery of power to a retinal prosthesis
US9331791B2 (en) 2014-01-21 2016-05-03 Nano Retina Ltd. Transfer of power and data
CN110740776A (en) * 2017-03-23 2020-01-31 高丽大学校产学协力团 Artificial retinal system for improving contrast sensitivity
CN110740776B (en) * 2017-03-23 2023-06-06 高丽大学校产学协力团 Artificial retina system for improving contrast sensitivity
EP3461529A1 (en) 2017-09-27 2019-04-03 Pixium Vision SA Tip, inserter attachment and delivery device
WO2019063655A1 (en) 2017-09-27 2019-04-04 Pixium Vision Sa Tip, inserter attachment and delivery device
CN109701157A (en) * 2017-12-29 2019-05-03 深圳硅基仿生科技有限公司 Radio-frequency signal detection device and retina stimulator with detection coil
CN109711286A (en) * 2018-12-11 2019-05-03 中国科学院深圳先进技术研究院 A kind of control method and device based on artificial retina spatial perception
CN109711286B (en) * 2018-12-11 2022-11-11 中国科学院深圳先进技术研究院 Control method and device based on artificial retina space perception
CN115376391A (en) * 2022-08-19 2022-11-22 中国科学技术大学苏州高等研究院 Three-dimensional eyeball imitation body and preparation method and application thereof

Similar Documents

Publication Publication Date Title
US5016633A (en) Artificial retina device
US5024223A (en) Artificial retina device
US6389317B1 (en) Multi-phasic microphotodetector retinal implant with variable voltage and current capability
US7139612B2 (en) Multi-phasic microphotodiode retinal implant and adaptive imaging retinal stimulation system
US7031776B2 (en) Methods for improving damaged retinal cell function
US7003354B2 (en) Artificial retina device with stimulating and ground return electrodes disposed on opposite sides of the neuroretina and method of attachment
AU2001243665A1 (en) Multi-phasic microphotodetector retinal implant with variable voltage and current capability and apparatus for insertion
AU2002352103A1 (en) Methods for improving damaged retinal cell function

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: OPTOBIONICS CORPORATION, ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHOW, ALAN Y.;REEL/FRAME:009075/0395

Effective date: 19980303

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: POLARIS VENTURE PARTNERS FOUNDERS' FUND, L.P., MAS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND III,

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: POLARIS VENTURE PARTNERS FOUNDERS' FUND III, L.P.,

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: CHO, ALAN, ILLINOIS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: ARCH V ENTREPRENEURS FUND, L.P., ILLINOIS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: ARCH VENTURE FUND III, L.P., ILLINOIS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: ARCH VENTURE FUND V, L.P., ILLINOIS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: POLARIS VENTURE PARTNERS III, L.P., MASSACHUSETTS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: POLARIS VENTURE PARTNERS, L.P., MASSACHUSETTS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: ATV ENTREPRENEURS V, L.P., MASSACHUSETTS

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: MEDTRONIC INTERNATIONAL, LTD., MINNESOTA

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

Owner name: ADVANCED TECHNOLOGY VENTURES V, L.P., MASSACHUSETT

Free format text: SECURITY AGREEMENT;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:019181/0882

Effective date: 20070412

AS Assignment

Owner name: IMI INTELLIGENT MEDICAL IMPLANTS AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OPTOBIONICS CORPORATION;REEL/FRAME:020507/0679

Effective date: 20070921